Biotech News
Afrigen Biologics Secures $6.2 Million Grant to Develop mRNA Vaccine for Rift Valley Fever
Afrigen Biologics, a South African biotechnology company, has been awarded a $6.2 million grant by the Coalition for Epidemic Preparedness Innovations (CEPI) to advance research into an mRNA-based vaccine for Rift Valley fever. The disease, typically transmitted by mosquitoes, has
22 January 2025